Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000546340 | SCV000641246 | uncertain significance | Congenital myasthenic syndrome 4A | 2021-08-24 | criteria provided, single submitter | clinical testing | This sequence change affects codon 441 of the CHRNE mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the CHRNE protein. This variant is present in population databases (rs758517310, ExAC 0.02%). This variant has not been reported in the literature in individuals affected with CHRNE-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001834786 | SCV002093373 | uncertain significance | Congenital myasthenic syndrome | 2019-10-28 | no assertion criteria provided | clinical testing |